Analysis of the method for conversion between levels of HbA1c and glycated albumin by linear regression analysis using a measurement error model

Diabetes Research and Clinical Practice

Volumn 84, Issue 3, 2009, Pages 224-229

  Tahara, Yasuhiro ^a  

^a Meimai Central Hospital   (Japan)

Author keywords

Glycated albumin; HbA1c; Linear regression analysis; Measurement error model

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DIABETIC DIET; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN;

EID: 67349088483     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.03.014     Document Type: Article

References (24)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. Tahara Y., and Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients (letter). Diabetes Care 16 (1993) 1313-1314
4. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18 (1995) 440-447
5. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., Peterson C.M., et al. Tests of glycemia in diabetes. Diabetes Care 27 (2004) 1761-1773
6. Shima K., Ito N., Abe F., Hirota M., Yano M., Yamamoto Y., et al. High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia 31 (1988) 627-631
7. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., and Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin. Chim. Acta 324 (2002) 61-71
8. Inaba M., Okuno S., Kumeda Y., Yamada S., Imanishi Y., Tabata T., et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 18 (2007) 896-903
9. Paroni R., Ceriotti F., Galanello R., Leoni G.B., Panico A., Scurati E., et al. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin. Biochem. 40 (2007) 1398-1405
10. 1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr. J. 54 (2007) 139-144
11. 1c ratio. Rev. Diabet. Stud. 4 (2007) 44-48
12. Yoshiuchi K., Matsuhisa M., Katakami N., Nakatani Y., Sakamoto K., Matsuoka T., et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr. J. 55 (2008) 503-507
13. Pu L.J., Lu L., Shen W.F., Zhang Q., Zhang R.Y., Zhang J.S., et al. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ. J. 71 (2007) 1067-1073
14. Okada T., Nakao T., Matsumoto H., Shino T., Nagaoka Y., Tomaru R., et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Int. Med. 46 (2007) 807-814
15. Shi K., Tahara Y., Noma Y., Yasukawa K., and Shima K. The response of glycated albumin to blood glucose change in the circulation in streptozotocin-diabetic rats-comparison of theoretical values with experimental data. Diabet. Res. Clin. Pract. 17 (1992) 153-160
16. Fuller W.A. Measurement Error Models (1987), Wiley & Sons Inc., New Jersey
17. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin. Chem. 50 (2004) 166-174
18. 1c I: comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann. Clin. Biochem. 42 (2005) 41-46
19. Day J.F., Ingebretsen C.G., Ingebretsen Jr. W.R., Baynes J.W., and Thorpe S.R. Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes 29 (1980) 524-527
20. Garlick R.L., and Mazer J.S. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J. Biol. Chem. 258 (1983) 6142-6146
21. Iberg N., and Flückiger R. Nonenzymatic glycosylation of albumin in vivo Identification of multiple glycosylated sites. J. Biol. Chem. 261 (1986) 13542-13545
22. Kisugi R., Kouzuma T., Yamamoto T., Akizuki S., Miyamoto H., Someya Y., et al. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin. Chim. Acta 382 (2007) 59-64
23. Virtue M.A., Furne J.K., Nuttall F.Q., and Levitt M.D. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27 (2004) 931-935
24. 1c in the Diabetes Control and Complications Trial. Diabetes Care 25 (2002) 275-278